by Michael Schubert, PhD | Sep 20, 2024 | Clinical Diagnostics Insider , Emerging Tests-dtet , Testing Trends-dtet
Recent advances in pharmacogenomic testing—and their role in ensuring safe, effective treatment selection for precision oncology
Subscribe to View Start a Free Trial for immediate access to this article
Try For Free
by Glenn S. Demby | Mar 15, 2023 | News , Open Content
New Advisory Opinion 23-01 is similar to other arrangements the OIG has approved in the past.
by Glenn S. Demby | Nov 21, 2022 | Clinical Diagnostics Insider , Diagnostic Testing and Emerging Technologies , Emerging Tests-dtet
Recent study shows the new test can identify a widespread and dangerous class of synthetic cannabinoids called BZO-CHMOXIZID.
Subscribe to View Start a Free Trial for immediate access to this article
Try For Free
by Glenn S. Demby | Oct 3, 2022 | Clinical Diagnostics Insider , Diagnostic Testing and Emerging Technologies , Special Focus-dtet
A recent study shows pharmacogenetic testing can help caregivers make better decisions when prescribing antidepressants.
Subscribe to View Start a Free Trial for immediate access to this article
Try For Free
by Rachel Muenz | Apr 12, 2022 | Articles , News , Open Content
While labs weren’t featured in this week’s enforcement actions, clinics and hospitals, and individuals involved in these organizations, were in hot water, mainly for False Claims Act violations. April 6: The former owner of a cash-only pain management clinic in...